HUDSON, Mass., Aug. 17 /PRNewswire/ -- Hypertronics Corporation, a Smiths Interconnect business and world-leading provider of high performance interconnect solutions for the most demanding applications today announced that its HyperGrip((R)) series circular connectors were selected by Biosense Webster, Inc. for its new CARTO((R)) 3 Navigation System. Hypertronics HyperGrip (HG) series was chosen for its optimal signal reliability and ease of use as a push pull connector.
Hypertronics Hypertac((R)) system is a unique contact design characterized by a wire basket technology which encapsulates a male pin and guarantees continuous signal integrity especially critical in medical applications where machine failure is often life threatening. HyperGrip is a user-configurable circular connector which is color-coded and customer-keyable for accurate and quick connections on medical equipment. HyperGrip is designed to meet medical industry requirements such as finger-proofing to IEC60601, flammability rated to UL94 V0, and is compatible with most sterilization requirements. It also incorporates the renowned performance of the Hypertac((R) )contact technology which provides high mating cycle, low insertion force and the high reliability required for the medical market.
The CARTO((R)) 3 Navigation System was previewed at the Heart Rhythm Society's (HRS) 30(th) Annual Scientific Sessions during Heart Rhythm 2009 in May 2009 and at EUROPACE, the official Congress of the European Heart Rhythm Association in Berlin in June 2009. The CARTO((R)) 3 System provides unparalleled views of the electrical activity of the heart through real-time data on 3-D, color-coded cardiac maps. It also ensures precise real-time tracking of catheter location, allowing for safe and accurate diagnosis. Designed to minimize RF applications, unnecessary radiation exposure and procedure times, the CARTO((R)) System 3 Navigation System improves location accuracy and site-targeting results while maintaining an excellent safety profile. The CARTO((R)) 3 System offers three unique features: Advanced Catheter Location (ACL) Technology, Fast Anatomical Mapping (FAM), and a streamlined workflow feature set referred to as CONNECTION OF CHOICE((TM)). These three features work in tandem to enhance a physician's ability to treat an array of simple and complex cardiac arrhythmias.
The CARTO((R)) 3 System is currently under 510(k) review at the U.S. Food and Drug Administration for use in the U.S. The CARTO((R)) 3 System will be released throughout the European Union and Canada in the third quarter of 2009.
|SOURCE Hypertronics Corporation|
Copyright©2009 PR Newswire.
All rights reserved